Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Multiple endocrine neoplasia type 1.

Gerard M Doherty¹

¹NW Thompson Professor of Surgery, University of Michigan, Ann Arbor, Michigan, USA. gerardd@umich.edu

Journal of Surgical Oncology

|February 19, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient-Reported Outcome Measures Used in Primary Hyperparathyroidism: A Scoping Review.

Annals of surgical oncology·2026

Same author

Bones, Stones, Groans, Moans, and a Path Forward With PROMs.

JAMA surgery·2025

Same author

Streamlining Health Care Access for Patients With Primary Hyperparathyroidism: A Quality Improvement Pilot Program.

The Journal of surgical research·2025

Same author

Variation in commercial prices for thyroidectomy and parathyroidectomy at US hospitals.

American journal of surgery·2024

Same author

Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial.

JAMA oncology·2024

Same author

Opportunities to improve the diagnosis and treatment of primary hyperparathyroidism: retrospective cohort study.

Gland surgery·2024

Same journal

The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

Journal of surgical oncology·2026

Same journal

"It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

Journal of surgical oncology·2026

Same journal

A Tale of Two Pathways: Same-Surgeon Versus Different-Surgeon Resection After Second Surgical Opinion.

Journal of surgical oncology·2026

Same journal

How I Do It: The Life and Work of a Rubber Band in Robotic Liver Parenchymal Transection.

Journal of surgical oncology·2026

Same journal

New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer Surgery.

Journal of surgical oncology·2026

Same journal

Performance of Survival Prediction Tools in Patients With Gastrointestinal Stromal Tumors: A Systematic Review and Meta-Analysis.

Journal of surgical oncology·2026

See all related articles

Multiple endocrine neoplasia-1 (MEN-1) is an inherited syndrome caused by MEN1 gene mutations. Management focuses on detecting and caring for associated tumors like parathyroid, pancreatic, and pituitary adenomas.

Area of Science:

Endocrinology
Genetics
Oncology

Background:

Multiple endocrine neoplasia-1 (MEN-1) is an autosomal dominant inherited syndrome.
It results from inactivating mutations in the MEN1 gene, which encodes the tumor-suppressor protein menin.
MEN-1 is characterized by specific neoplastic manifestations.

Purpose of the Study:

To outline the key features and manifestations of MEN-1.
To emphasize the importance of understanding and managing this condition.
To provide guidance on detecting and caring for MEN-1 associated tumors.

Main Methods:

Review of the genetic basis of MEN-1, focusing on MEN1 gene mutations.
Description of the common and less common neoplastic manifestations.

Related Experiment Videos

Discussion of clinical management strategies for MEN-1 patients.

Main Results:

MEN-1 commonly involves hyperparathyroidism (parathyroid adenomas), pancreatic neuroendocrine tumors, and pituitary adenomas.
Less frequent neoplastic conditions can also occur in MEN-1 patients.
Early detection and proactive management are crucial for patient care.

Conclusions:

MEN-1 is a complex inherited endocrine neoplasia syndrome.
While incurable, MEN-1 is manageable with comprehensive care.
Knowledge of potential complications and management approaches is essential for healthcare providers.